Diagnosis: Necrobiosis lipoidica
A 55-year-old woman with a 5-year history of type 2 diabetes presents with yellow-brown atrophic plaques on her pretibial skin. The lesions are asymptomatic but have progressively enlarged, raising concerns for underlying pathology.
A 55-year-old woman with a 5-year history of type 2 diabetes presents with yellow-brown atrophic plaques on her pretibial skin. The lesions are asymptomatic but have progressively enlarged over the past year, prompting the patient to seek evaluation. On examination, there are well-defined, atrophic plaques with telangiectasia and hyperpigmentation, primarily localized to the pretibial region.Distribution: Predominantly on the pretibial skin.Color: Yellow-brown, with a shiny appearance.Texture: Atrophic and smooth.Associated findings: Possible telangiectasia and surrounding erythema.Symptoms: Lesions are typically asymptomatic.
The patient reports that the lesions began approximately one year ago and have slowly increased in size. She denies any history of trauma or other skin conditions. There is no known family history of similar skin lesions. She has been managing her diabetes with metformin and lifestyle modifications but has had difficulty achieving optimal glycemic control. There are no recent changes in her medications or diet.Onset: Lesions began approximately one year ago.Triggers: No known triggers or preceding events.Prior treatments: None attempted for the skin lesions.Medical history: Type 2 diabetes, well-controlled with metformin.Family history: No family history of skin disorders.Social history: Non-smoker, moderate alcohol use.
Acute / First-Line ManagementTopical corticosteroids: High-potency corticosteroids, such as clobetasol propionate ointment, applied twice daily may be used to reduce inflammation.Intralesional corticosteroids: Triamcinolone acetonide (10-40 mg/mL) can be injected directly into the plaques for localized treatment.Supportive care: Education on diabetes management and skin care to prevent secondary infections.Workup and Diagnostic ConfirmationSkin biopsy: A biopsy should be performed to confirm the diagnosis and rule out other conditions. Histopathological findings typically show a loss of collagen and fat.Laboratory tests: Assess glycemic control through HbA1c levels, as better diabetes management may improve skin lesions.Long-Term ManagementRegular follow-up: Monitor skin lesions for changes and assess diabetes control.Consider systemic therapies: In refractory cases, systemic agents such as methotrexate or mycophenolate mofetil may be considered.Patient education: Emphasize the importance of glycemic control in managing skin manifestations.
Granuloma annulare: Characterized by annular plaques primarily on the dorsal surfaces of hands and feet. Biopsy shows a palisaded granulomatous infiltrate.Diabetic dermopathy: Presents as brown, atrophic macules, often on the shins, and is associated with diabetes but lacks the telangiectasia seen here.Stasis dermatitis: Common in patients with venous insufficiency, presenting with erythema, scaling, and edema, typically around the ankles.Psoriasis: Well-defined plaques with silvery scales, often found on extensor surfaces, and may have a family history associated.Necrobiosis lipoidica diabeticorum: Similar to the presented case but may have more pronounced vascular changes and is often associated with diabetes.Cutaneous sarcoidosis: Can present with similar plaques but typically involves deeper dermal structures and may show non-caseating granulomas on biopsy.Lichen planus: Presents as violaceous, pruritic papules, with possible involvement of mucous membranes.Fixed drug eruption: Characterized by well-defined plaques that recur at the same site upon re-exposure to the offending drug.
High-Yield PearlsChronic condition: Necrobiosis lipoidica is often associated with long-standing diabetes and may signify poor metabolic control.Histopathology: A biopsy is essential for diagnosis, showing characteristic collagen degeneration and fat loss.Management focus: Emphasis on glycemic control can improve skin lesions and overall health.Topical treatments: High-potency topical corticosteroids are first-line for symptomatic relief.Potential complications: Patients may develop ulcerations in severe cases, necessitating prompt intervention.Understanding the relationship between metabolic control and skin manifestations is crucial in managing patients with diabetes.
Tags: necrobiosis lipoidica, diabetes